Ametek Research Development vs Total Revenue Analysis

0HF7 Stock

183.87 1.44 0.79%

Ametek financial indicator trend analysis is way more than just evaluating Ametek Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ametek Inc is a good investment. Please check the relationship between Ametek Research Development and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ametek Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Research Development vs Total Revenue

Research Development vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ametek Inc Research Development account and Total Revenue. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Ametek's Research Development and Total Revenue is 0.46. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Ametek Inc, assuming nothing else is changed. The correlation between historical values of Ametek's Research Development and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Ametek Inc are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Research Development i.e., Ametek's Research Development and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.46

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Research Development

Total Revenue

Total revenue comprises all receipts Ametek Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Ametek's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ametek Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ametek Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to gain to about 729.3 M in 2024, whereas Tax Provision is likely to drop slightly above 237.6 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	1.9B	2.1B	2.4B	2.5B
Total Revenue	5.5B	6.2B	6.6B	6.9B

Gross Profit Total Revenue

Ametek fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Current Deferred Revenue	Short Term Investments	Common Stock
Total Assets		0.94	0.97	0.93	0.99	0.99	0.91	0.99	0.25	1.0	-0.03	0.25	0.96	-0.83	0.91	0.96	0.92	-0.77	0.98	0.97	0.76	0.99	0.9	0.68	0.7	0.49
Short Long Term Debt Total	0.94		0.93	0.88	0.89	0.92	0.95	0.92	0.33	0.93	-0.03	0.33	0.94	-0.9	0.95	0.88	0.89	-0.83	0.99	0.95	0.74	0.93	0.9	0.51	0.76	0.59
Other Current Liab	0.97	0.93		0.9	0.95	0.93	0.91	0.96	0.25	0.97	-0.12	0.25	0.97	-0.84	0.9	0.93	0.86	-0.79	0.96	0.94	0.71	0.97	0.93	0.57	0.71	0.53
Total Current Liabilities	0.93	0.88	0.9		0.92	0.97	0.92	0.91	0.02	0.94	0.3	0.02	0.92	-0.76	0.74	0.94	0.88	-0.62	0.92	0.86	0.94	0.9	0.82	0.63	0.62	0.31
Total Stockholder Equity	0.99	0.89	0.95	0.92		0.98	0.87	0.99	0.22	0.99	-0.02	0.22	0.94	-0.78	0.86	0.96	0.91	-0.73	0.95	0.95	0.75	0.99	0.87	0.73	0.65	0.43
Property Plant And Equipment Net	0.99	0.92	0.93	0.97	0.98		0.91	0.97	0.17	0.99	0.11	0.17	0.94	-0.79	0.84	0.96	0.94	-0.72	0.96	0.93	0.84	0.97	0.84	0.72	0.64	0.38
Net Debt	0.91	0.95	0.91	0.92	0.87	0.91		0.88	0.03	0.91	0.06	0.03	0.95	-0.84	0.86	0.91	0.9	-0.74	0.95	0.85	0.81	0.91	0.88	0.56	0.68	0.5
Retained Earnings	0.99	0.92	0.96	0.91	0.99	0.97	0.88		0.28	0.99	-0.08	0.28	0.94	-0.79	0.9	0.95	0.92	-0.81	0.97	0.96	0.72	0.99	0.86	0.72	0.66	0.45
Cash	0.25	0.33	0.25	0.02	0.22	0.17	0.03	0.28		0.2	-0.36	1.0	0.14	-0.31	0.47	0.06	0.14	-0.44	0.29	0.46	-0.13	0.23	0.23	-0.07	0.37	0.48
Non Current Assets Total	1.0	0.93	0.97	0.94	0.99	0.99	0.91	0.99	0.2		-0.02	0.2	0.96	-0.81	0.89	0.97	0.93	-0.75	0.98	0.95	0.77	0.99	0.89	0.7	0.68	0.47
Non Currrent Assets Other	-0.03	-0.03	-0.12	0.3	-0.02	0.11	0.06	-0.08	-0.36	-0.02		-0.36	-0.04	0.07	-0.31	0.08	0.02	0.34	-0.04	-0.08	0.58	-0.13	-0.11	-0.03	-0.12	-0.43
Cash And Short Term Investments	0.25	0.33	0.25	0.02	0.22	0.17	0.03	0.28	1.0	0.2	-0.36		0.14	-0.31	0.47	0.06	0.14	-0.44	0.29	0.46	-0.13	0.24	0.23	-0.07	0.37	0.48
Net Receivables	0.96	0.94	0.97	0.92	0.94	0.94	0.95	0.94	0.14	0.96	-0.04	0.14		-0.87	0.91	0.97	0.89	-0.74	0.97	0.93	0.75	0.96	0.96	0.55	0.75	0.59
Common Stock Shares Outstanding	-0.83	-0.9	-0.84	-0.76	-0.78	-0.79	-0.84	-0.79	-0.31	-0.81	0.07	-0.31	-0.87		-0.88	-0.79	-0.75	0.65	-0.89	-0.87	-0.61	-0.82	-0.89	-0.33	-0.71	-0.61
Non Current Liabilities Total	0.91	0.95	0.9	0.74	0.86	0.84	0.86	0.9	0.47	0.89	-0.31	0.47	0.91	-0.88		0.82	0.84	-0.85	0.95	0.94	0.51	0.92	0.9	0.48	0.77	0.72
Inventory	0.96	0.88	0.93	0.94	0.96	0.96	0.91	0.95	0.06	0.97	0.08	0.06	0.97	-0.79	0.82		0.89	-0.69	0.94	0.91	0.8	0.95	0.9	0.67	0.64	0.42
Other Current Assets	0.92	0.89	0.86	0.88	0.91	0.94	0.9	0.92	0.14	0.93	0.02	0.14	0.89	-0.75	0.84	0.89		-0.73	0.92	0.88	0.76	0.92	0.78	0.69	0.62	0.41
Other Stockholder Equity	-0.77	-0.83	-0.79	-0.62	-0.73	-0.72	-0.74	-0.81	-0.44	-0.75	0.34	-0.44	-0.74	0.65	-0.85	-0.69	-0.73		-0.8	-0.8	-0.42	-0.79	-0.65	-0.55	-0.54	-0.43
Total Liab	0.98	0.99	0.96	0.92	0.95	0.96	0.95	0.97	0.29	0.98	-0.04	0.29	0.97	-0.89	0.95	0.94	0.92	-0.8		0.97	0.75	0.98	0.93	0.59	0.75	0.58
Total Current Assets	0.97	0.95	0.94	0.86	0.95	0.93	0.85	0.96	0.46	0.95	-0.08	0.46	0.93	-0.87	0.94	0.91	0.88	-0.8	0.97		0.67	0.95	0.91	0.54	0.75	0.59
Short Term Debt	0.76	0.74	0.71	0.94	0.75	0.84	0.81	0.72	-0.13	0.77	0.58	-0.13	0.75	-0.61	0.51	0.8	0.76	-0.42	0.75	0.67		0.71	0.63	0.52	0.48	0.11
Intangible Assets	0.99	0.93	0.97	0.9	0.99	0.97	0.91	0.99	0.23	0.99	-0.13	0.24	0.96	-0.82	0.92	0.95	0.92	-0.79	0.98	0.95	0.71		0.9	0.69	0.7	0.52
Accounts Payable	0.9	0.9	0.93	0.82	0.87	0.84	0.88	0.86	0.23	0.89	-0.11	0.23	0.96	-0.89	0.9	0.9	0.78	-0.65	0.93	0.91	0.63	0.9		0.36	0.8	0.72
Current Deferred Revenue	0.68	0.51	0.57	0.63	0.73	0.72	0.56	0.72	-0.07	0.7	-0.03	-0.07	0.55	-0.33	0.48	0.67	0.69	-0.55	0.59	0.54	0.52	0.69	0.36		0.07	-0.1
Short Term Investments	0.7	0.76	0.71	0.62	0.65	0.64	0.68	0.66	0.37	0.68	-0.12	0.37	0.75	-0.71	0.77	0.64	0.62	-0.54	0.75	0.75	0.48	0.7	0.8	0.07		0.8
Common Stock	0.49	0.59	0.53	0.31	0.43	0.38	0.5	0.45	0.48	0.47	-0.43	0.48	0.59	-0.61	0.72	0.42	0.41	-0.43	0.58	0.59	0.11	0.52	0.72	-0.1	0.8

Click cells to compare fundamentals

Ametek Account Relationship Matchups

Ametek fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.8B	10.4B	11.9B	12.4B	15.0B	15.8B
Short Long Term Debt Total	2.8B	2.4B	2.5B	2.4B	3.4B	3.5B
Other Current Liab	321.1M	304.8M	396.0M	388.8M	441.9M	464.0M
Total Current Liabilities	1.4B	1.1B	1.6B	1.6B	2.9B	3.0B
Total Stockholder Equity	5.1B	5.9B	6.9B	7.5B	8.7B	9.2B
Property Plant And Equipment Net	728.6M	693.8M	787.1M	805.9M	1.1B	1.2B
Net Debt	2.4B	1.2B	2.2B	2.0B	3.0B	3.1B
Retained Earnings	6.4B	7.1B	7.9B	8.9B	9.9B	10.4B
Cash	393.0M	1.2B	346.8M	345.4M	409.8M	211.8M
Non Current Assets Total	7.8B	7.8B	9.8B	9.9B	12.2B	12.8B
Non Currrent Assets Other	(815.9M)	(826.1M)	(1.1B)	(1.1B)	453.0M	475.6M
Cash And Short Term Investments	393.0M	1.2B	346.8M	345.4M	409.8M	214.8M
Net Receivables	744.8M	597.5M	829.2M	919.3M	1.0B	1.1B
Common Stock Shares Outstanding	229.4M	231.2M	232.8M	231.5M	231.5M	199.5M
Liabilities And Stockholders Equity	9.8B	10.4B	11.9B	12.4B	15.0B	15.8B
Non Current Liabilities Total	3.3B	3.3B	3.5B	3.4B	3.4B	3.6B
Inventory	624.6M	559.2M	769.2M	1.0B	1.1B	1.2B
Other Current Assets	263.4M	153.0M	183.6M	219.1M	269.5M	282.9M
Other Stockholder Equity	(741.6M)	(643.5M)	(560.5M)	(808.7M)	(727.9M)	(691.5M)
Total Liab	4.7B	4.4B	5.0B	5.0B	6.3B	6.6B
Total Current Assets	2.0B	2.5B	2.1B	2.5B	2.8B	3.0B
Accumulated Other Comprehensive Income	(533.1M)	(504.5M)	(470.4M)	(574.9M)	(484.9M)	(460.7M)
Short Term Debt	540.5M	177.2M	362.4M	272.4M	1.5B	1.6B
Intangible Assets	3.0B	2.9B	3.7B	3.7B	4.2B	4.4B
Accounts Payable	377.2M	360.4M	470.3M	497.1M	516.6M	542.4M
Current Deferred Revenue	156.8M	194.6M	298.7M	357.7M	375.5M	394.3M
Common Stock	2.7M	2.7M	2.7M	2.7M	2.7M	1.8M
Good Will	4.0B	4.2B	5.2B	5.4B	6.4B	6.8B
Other Assets	271.4M	283.7M	1.0	372.6M	428.5M	449.9M
Other Liab	889.3M	922.6M	1.1B	1.1B	1.3B	1.0B
Net Tangible Assets	(1.7B)	(899.3M)	(1.7B)	(1.2B)	(1.4B)	(1.5B)
Long Term Debt	2.3B	2.3B	2.3B	2.2B	2.6B	2.4B
Property Plant Equipment	728.6M	693.8M	787.1M	805.9M	926.8M	744.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Ametek Stock Analysis

When running Ametek's price analysis, check to measure Ametek's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ametek is operating at the current time. Most of Ametek's value examination focuses on studying past and present price action to predict the probability of Ametek's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ametek's price. Additionally, you may evaluate how the addition of Ametek to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ametek Research Development vs Total Revenue Analysis

Research Development vs Total Revenue

Research Development vs Total Revenue Correlation Analysis

Correlation Coefficient

Research Development

Total Revenue

Ametek fundamental ratios Correlations

Ametek Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ametek fundamental ratios Accounts

Also Currently Popular

Additional Tools for Ametek Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Assets
Intangible Assets	+ 0.99	Total Assets

Common Stock Shares Outstanding	- 0.9	Short Long Term Debt Total
Accounts Payable	- 0.89	Common Stock Shares Outstanding
Total Liab	- 0.89	Common Stock Shares Outstanding
Non Current Liabilities Total	- 0.88	Common Stock Shares Outstanding
Total Current Assets	- 0.87	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.87	Net Receivables